TRIDERMA- hydroquinone, tretinoin, fluocinolone acetonide cream

Country: Amerika Syarikat

Bahasa: Inggeris

Sumber: NLM (National Library of Medicine)

Bahan aktif:

TRETINOIN (UNII: 5688UTC01R) (TRETINOIN - UNII:5688UTC01R), FLUOCINOLONE ACETONIDE (UNII: 0CD5FD6S2M) (FLUOCINOLONE ACETONIDE - UNII:0CD5FD6S2M), HYDROQUINONE (UNII: XV74C1N1AE) (HYDROQUINONE - UNII:XV74C1N1AE)

Boleh didapati daripada:

Pella Pharmaceutical Co. Ltd

Laluan pentadbiran:

TOPICAL

Jenis preskripsi:

PRESCRIPTION DRUG

Tanda-tanda terapeutik:

Triderma is indicated for the short-term intermittent treatment of moderate to severe melasma of the face, in the presence of measures for sun avoidance, including the use of sunscreens. Triderma is contraindicated in individuals with a history of hypersensitivity, allergy, or intolerance to this product or any of its components.

Ringkasan produk:

30 g packs.

Status kebenaran:

unapproved drug other

Ciri produk

TRIDERMA- HYDROQUINONE, TRETINOIN, FLUOCINOLONE ACETONIDE CREAM
PELLA PHARMACEUTICAL CO. LTD
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this_
_labeling has not been approved by FDA. For further information about
unapproved_
_drugs, click here._
----------
TRIDERMA
COMPOSITION
Each 1 g contains: Hydroquinone 40 mg, Tretinoin 0.5 mg and
Fluocinolone Acetonide
0.1 mg.
Excipients: Emulsifying Wax, Cetyl Alcohol, Glycerin, Cetostaeryl
Alcohol, Glycerol
Monostearate, Stearic Acid, White Soft Paraffin, Sodium Metabisulfite,
Methylparaben,
Citric Acid, Butylated Hydroxyanisole, Propylparaben, and Purified
Water.
PROPERTIES
Fluocinolone acetonide is a synthetic fluorinated corticosteroid for
topical dermatological
use and is classified therapeutically as an anti-inflammatory. It is a
white crystalline
powder that is odorless and stable in light. Hydroquinone is
classified therapeutically as a
de-pigmenting agent. It is prepared from the reduction of
p-benzoquinone with sodium
bisulfite. It occurs as fine white needles that darken on exposure to
air. Tretinoin is all-
trans-retinoic acid formed from the oxidation of the aldehyde group of
retinene to a
carboxyl group. It occurs as yellow to light-orange crystals or
crystalline powder with a
characteristic odor of ensilage. It is highly reactive to light and
moisture. Tretinoin is
classified therapeutically as a keratolytic.
INDICATIONS
TRIDERMA is indicated for the short-term intermittent treatment of
moderate to severe
melasma of the face, in the presence of measures for sun avoidance,
including the use
of sunscreens.
CONTRAINDICATIONS
TRIDERMA is contraindicated in individuals with a history of
hypersensitivity, allergy, or
intolerance to this product or any of its components.
PRECAUTIONS
TRIDERMA contains hydroquinone and tretinoin that may cause mild to
moderate
irritation. Local irritation, such as skin reddening, peeling, mild
burning sensation,
dryness, and pruritus may be expected at the site of application.
Transient skin
reddeni